Psychiatric comorbidity in epilepsy and end stage renal disease

Wisconsin Medical Journal

Volumn 103, Issue 6, 2004, Pages 64-68

  Bresnahan, David B ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b ROGERS MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CLOMIPRAMINE; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; ILLICIT DRUG; LAMOTRIGINE; MAPROTILINE; METOCLOPRAMIDE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PAROXETINE; PHENOBARBITAL; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; TIAGABINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE; VIGABATRIN;

ALCOHOL ABUSE; COMORBIDITY; DELIRIUM; DEPRESSION; DISEASE ASSOCIATION; DRUG ABUSE; DRUG CHOICE; DRUG CONTRAINDICATION; EARLY DIAGNOSIS; ELECTROLYTE DISTURBANCE; EPILEPSY; HUMAN; HYPERCALCEMIA; INSOMNIA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MENTAL DISEASE; ORGANIC PSYCHOSYNDROME; PATIENT REFERRAL; REVIEW; SIDE EFFECT; UREMIA; CHRONIC KIDNEY FAILURE;

COMORBIDITY; EPILEPSY; HUMANS; KIDNEY FAILURE, CHRONIC; MENTAL DISORDERS;

EID: 16644362890     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Torta R, Keller R. Behavioral, psychotic, and anxiety disorders in epilepsy: etiology, clinical features, and therapeutic implications. Epilepsia. 1999;40(Suppl 10):S2-S20.
2. Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry. 2003;54:388-398.
3. Kanner AM. Depressive disorders in epilepsy. Neurology. 1999;53(5)(Suppl 2):S26-S32.
4. Weigartz P, Seidenberg M, Woodard A, Gidal B, Hermann B. Co-morbid psychiatric disorder in epilepsy: recognition and etiology of depression. Neurology. 1999;53(5)(Suppl 2):S3-S8.
5. Harden CL, Goldstein MA. Mood disorders in patients with epilepsy. CNS Drugs. 2002;16(5):291-302.
6. Harden CL. The co-morbidity of depression and epilepsy, epidemiology, etiology, and treatment. Neurology. 2002;59(Suppl 4):S48-S55.
7. Adachi N, Matsuura M, Okubo Y, et al. Predictive variables of interictal psychosis in epilepsy. Neurology. 2000;55:1310-1314.
8. Koch-Stoecker S. Antipsychotic drugs and epilepsy: indications and treatment guidelines. Epilepsia. 2002;43(Suppl 2):19-24.
9. Vasquez B, Devinsky O. Epilepsy and anxiety. Epilepsy Behav. 2003;4:S20-S25.
10. LaFrance WC, Devinsky O. The treatment of nonepileptic seizures: historical perspectives and future directions. Epilepsia. 2004;45(Suppl 2):15-21.
11. Bowman ES. Pseudoseizures. Psychol Clin North Am. 1998;21(3):649-657.
12. Finkelstein FO, Watnick S, Finkelstein SH, Wuerth D. The treatment of depression in patients maintained on dialysis. J Psychosom Res. 2002;53:957-960.
13. Kimmel PL, Thamer M, Richard CM, Ray NF. Psychiatric illness in patients with end-stage renal disease. Am J Med. 1998:105:214-221.
14. Kimmel PL. Depression in patients with chronic renal disease. What we know and what we need to know. J Psychosom Res. 2002;53:951-956.
15. Kimmel PL. Psychosocial factors in adult end-stage renal disease patients treated with hemodialysis: correlates and outcomes. Am J Kidney Dis. 2000;35(4)(Suppl 1):S132-S140.
16. Wuerth D, Finkelstein SH, Ciarcia J, Peterson R, Kliger AS, Finkelstein FO. Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis. 2001;37(5):1011- 1017.
17. Beck AT, Steer RA, Brown GK. BDI-II: Beck Depression Inventory Manual. 2nd ed. Boston, Mass: Harcourt, Brace; 1996.
18. Aronoff GR, Berns JS, Brier ME, et al. Drug prescribing in renal failure. In: Dosing Guidelines for Adults. 4th ed. Philadelphia, PA: ACP-ASIM; 1999:91.
19. Cohen LM, Tessier EG, Germain MJ, Levy NB. Update on psychotropic medication use in renal disease. Psychosom. 2004;45(1):34-48.
20. Hedge A, Veis JH, Seidman A, Khan S, Moore J. High prevalence of alcoholism in dialysis patients. Am J Kidney Dis. 2000;35(6):1039-1043.
21. Crowe AV, Howse M, Bell GM, Henry JA. Substance abuse and the kidney. Q J Med. 2000;93:147-152.
22. Cohen LM, Germain MJ, Tessier EG. Neuropsychiatric complications and psychopharmacology of end stage renal disease. In: Brady HR, Wilcox CS, eds. Therapy in Nephrology and Hypertension: A Companion to Brenner and Rector's The Kidney. 2nd ed. WB Sanders; 2003:731-746.
23. Vella JP, Waterman A. Psychiatric aspects of organ transplantation. Up To Date Online 12.2. 2004.
24. Baines LS, Joseph JT, Jindal RM. Emotional issues after kidney transplantation: a prospective psychotherapeutic study. Clin Transplantation. 2002;16(6):455-460.
25. Franklin JE, Paine RM. Psychiatric issues in organ transplantation. In: Stuart FP, Abecassis MM, Kaufman DB, eds. Organ Transplantation. 2nd ed. Landes Bioscience; 2003:378-399.